These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11667930)

  • 1. Linezolid and reversible myelosuppression.
    Arellano FM
    JAMA; 2001 Oct 24-31; 286(16):1973-4; discussion 1974. PubMed ID: 11667930
    [No Abstract]   [Full Text] [Related]  

  • 2. Linezolid and reversible myelosuppression.
    Green SL; Maddox JC; Huttenbach ED
    JAMA; 2001 Mar; 285(10):1291. PubMed ID: 11255382
    [No Abstract]   [Full Text] [Related]  

  • 3. Linezolid and reversible myelosuppression.
    Lawyer MC; Lawyer EZ
    JAMA; 2001 Oct 24-31; 286(16):1974. PubMed ID: 11667931
    [No Abstract]   [Full Text] [Related]  

  • 4. Linezolid and reversible myelosuppression.
    Abena PA; Mathieux VG; Scheiff JM; Michaux LM; Vandercam BC
    JAMA; 2001 Oct 24-31; 286(16):1973; author reply 1974. PubMed ID: 11667929
    [No Abstract]   [Full Text] [Related]  

  • 5. Hematologic effects of linezolid: summary of clinical experience.
    Gerson SL; Kaplan SL; Bruss JB; Le V; Arellano FM; Hafkin B; Kuter DJ
    Antimicrob Agents Chemother; 2002 Aug; 46(8):2723-6. PubMed ID: 12121967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombocytopenia and anemia associated with linezolid in patients with kidney failure.
    Mateu de Antonio J; Grau S; Morales-Molina JA; Marín-Casino M
    Clin Infect Dis; 2006 May; 42(10):1500; author reply 1501. PubMed ID: 16619168
    [No Abstract]   [Full Text] [Related]  

  • 7. Challenges with linezolid therapy and reversible pancytopenia.
    Nimeiri HS; Nemiary DS
    Ann Hematol; 2003 Aug; 82(8):533. PubMed ID: 12811516
    [No Abstract]   [Full Text] [Related]  

  • 8. Linezolid-Induced anemia and thrombocytopenia.
    Waldrep TW; Skiest DJ
    Pharmacotherapy; 2002 Jan; 22(1):109-12. PubMed ID: 11794421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematologic effects of antimicrobials: focus on the oxazolidinone linezolid.
    Kuter DJ; Tillotson GS
    Pharmacotherapy; 2001 Aug; 21(8):1010-3. PubMed ID: 11718489
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of linezolid-associated hematologic toxicities in a large veterans affairs medical center.
    Minson Q; Gentry CA
    Pharmacotherapy; 2010 Sep; 30(9):895-903. PubMed ID: 20795845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sideroblastic anemia after prolonged linezolid therapy].
    Kakimoto T; Nakazato T; Miura R; Kurai H; Yamashita D; Sagara Y; Ishida A
    Rinsho Ketsueki; 2008 Nov; 49(11):1566-8. PubMed ID: 19047790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serotonin syndrome associated with linezolid].
    Hernández-Lorente E; Broto PL; Brumós LG; Simeón Aznar CP
    Med Clin (Barc); 2009 Feb; 132(4):157-8. PubMed ID: 19211077
    [No Abstract]   [Full Text] [Related]  

  • 13. Linezolid-induced pure red blood cell aplasia.
    Monson T; Schichman SA; Zent CS
    Clin Infect Dis; 2002 Aug; 35(3):E29-31. PubMed ID: 12115113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linezolid induces ring sideroblasts.
    Willekens C; Dumezy F; Boyer T; Renneville A; Rossignol J; Berthon C; Cotteau-Leroy A; Mehiaoui L; Quesnel B; Preudhomme C
    Haematologica; 2013 Nov; 98(11):e138-40. PubMed ID: 24186315
    [No Abstract]   [Full Text] [Related]  

  • 15. Hematologic effects of linezolid in young children.
    Meissner HC; Townsend T; Wenman W; Kaplan SL; Morfin MR; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S186-92. PubMed ID: 14520145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linezolid-induced lactic acidosis followed by severe hypophosphatemia after discontinuation of linezolid.
    Miyawaki A; Ueda T; Nakao A; Adachi M; Ohya M; Yamada I; Takesue Y; Kotani J
    Surg Infect (Larchmt); 2013 Apr; 14(2):229-30. PubMed ID: 23464676
    [No Abstract]   [Full Text] [Related]  

  • 17. No effect of pyridoxine on the incidence of myelosuppression during prolonged linezolid treatment.
    Plachouras D; Giannitsioti E; Athanassia S; Kontopidou F; Papadopoulos A; Kanellakopoulou K; Giamarellou H
    Clin Infect Dis; 2006 Nov; 43(9):e89-91. PubMed ID: 17029128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombocytopenia secondary to linezolid administration: what is the risk?
    Orrick JJ; Johns T; Janelle J; Ramphal R
    Clin Infect Dis; 2002 Aug; 35(3):348-9. PubMed ID: 12115111
    [No Abstract]   [Full Text] [Related]  

  • 19. Linezolid-induced neuropathy.
    Corallo CE; Paull AE
    Med J Aust; 2002 Sep; 177(6):332. PubMed ID: 12225284
    [No Abstract]   [Full Text] [Related]  

  • 20. Linezolid-induced neuropathy.
    Legout L; Senneville E; Gomel JJ; Yazdanpanah Y; Mouton Y
    Clin Infect Dis; 2004 Mar; 38(5):767-8. PubMed ID: 14986270
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.